SOUTENIR LA RECHERCHE Soutenez la recherche sur la SLA
Rejoignez l'appel d'Olivier Goy, ambassadeur de l'Institut du Cerveau, et soutenez la recherche sur la sclérose latérale amyotrophique (SLA ou maladie de Charcot).
International Choose France for Science / Choose Europe for Science
Discover our hosting and collaboration modalities.
INSTITUTE Reception of Stéphanie DEBETTE at the French Académie des sciences
Stéphanie DEBETTE, Managing Director of Paris Brain Institute, was officially received under the dome of the Institut de France on the occasion of her induction into the Académie des Sciences.
Our latest news
Thanks to 7T fMRI, researchers from Paris Brain Institute and NeuroSpin, the CEA's neuroimaging centre, are exploring the neural substrate of visual imagery at very high resolution for the first time. Their results, publiés [i] in Cortex, pave the...
06.06.2025
Research, science & health
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025
Research, science & health
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025
Research, science & health
Paris Brain Institute is pleased to announce the opening of applications for the 2025-2026 academic year to the iMIND International Master Program - International Master In Neurodegenerative Diseases, a high-level training program run by Sorbonne...
04.16.2025
Teaching & training
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025
Research, science & health
Hélène Cheval is a lecturer at Sorbonne University – Paris Brain Institute and director of the iMIND Master 2 program.
03.21.2025
Portraits
Research at Paris Brain Institute
Since its creation, Paris Brain Institute has placed patients at the heart of its scientific and medical strategy.
-
846 Staff including 83% scientific, medical and paramedical staff (as at September 30, 2023)
-
29 Research teams selected by a Scientific Advisory Board
-
45 Nationalities (as at September 30, 2023)
-
12 Technical facilities and biobank
Understanding the brain
Every day, scientific research tells us a little more about the brain, the body’s control room for all cognition, memory and emotions. From the anatomy of the brain to the latest knowledge about consciousness and the different neurological diseases...
With longer life expectancies and the biological mechanisms at the origin of neurodegenerative diseases becoming increasingly complex, it is now estimated that, in France in 2020, 1.3 million people were affected by Alzheimer’s disease. Today, more...
Parkinson’s disease is the second-most common neurodegenerative condition after Alzheimer’s disease, and the main cause of Parkinsonian syndrome.
Multiple sclerosis (MS) is the second leading cause of acquired disability in young adults, after injury. It affects 120,000 people in France today, with 3,000 new cases diagnosed each year. This makes it a major public health issue, since it also...
Amyotrophic lateral sclerosis (ALS), or ‘Lou Gerhig’s disease’, is a progressive and fatal neuromuscular condition involving the gradual death of motor neurons, the neurons that control walking, speech, swallowing and breathing. This loss of motor...
A tumour is formed of cells that multiply in an uncontrolled way, taking over the surrounding cells and, to varying degrees, disrupting brain function. A brain tumour can develop in any area of the brain.
The word ‘epilepsy’ originates from a Greek word meaning ‘to seize’, reflecting the sudden and unpredictable onset of seizures. In France, 600,000 people are affected by this chronic neurological disease, which can present with different symptoms...
A cerebrovascular accident, or stroke, is a sudden onset condition that causes motor deficits (movement of the limbs), loss of sensation and/or language problems.
Autism, or autism spectrum disorder, is a neurodevelopmental disorder that has two main symptoms: persistent problems with communication and social interaction in a variety of contexts; and restricted and repetitive behaviour, interests and...
Mental health, an essential component of our overall health, is a state of well-being, and an ability of the mind to function normally and respond appropriately to environmental stimuli. Mental disorders occur when this state of well-being is...
Tourette’s syndrome (TS) was first identified in the 19th century by French neurologist Georges Gilles de la Tourette. It is a neuropsychiatric disorder with a genetic component characterised by sudden, brief and intermittent movements (motor tics)...
Although the word ‘bipolar’ is being increasingly used in the media, and sometimes misused, the disorder is in fact a serious and debilitating condition affecting around 3% of the population.
How support Paris Brain Institute?
And commit to it
-
Ten reasons to support Paris Brain Institute
Find out why we support Paris Brain Institute -
Provide direct and regular support for research
Find out how to make a monthly donation -
Transfer all or part of your estate to the Institute
Discover the different transmission modes -
Involving a company in the Institute's research mission
Find out how to become a corporate partner or sponsor